UK Diabetes Device Market Projects $2 Billion by 2032
NSW Government Allocates $10.7M to Enhance Drug and Alcohol Support in Far West
WHO Endorses First Single-Dose Treatment for P. vivax Malaria
Pacira Receives U.S. Patent to Protect EXPAREL Until 2044
Inari Medical Secures Reimbursement for ClotTriever in Japan
Sobi Highlights Robust Hematology Portfolio at ASH 2024
Vyepti Proves Effective in Reducing Severe Migraine Days, New Trial Shows
Gilead and Tubulis Form Exclusive Partnership to Develop ADC for Solid Tumors
FDA Accelerates Approval for Merck’s sac-TMT in Advanced Lung Cancer
Intra-Cellular Therapies Files FDA Supplemental Application for CAPLYTA in Depression Treatment
Shionogi’s Cefiderocol Gains Australian Approval for Resistant Infections
KIMMTRAK Receives NHS Funding for Uveal Melanoma Treatment in England
China Approves PharmaMar’s Zepzelca for Aggressive Lung Cancer
Novo Nordisk Reveals New Sickle Cell and Hemophilia Findings at ASH 2024
ADD4KIDS Launches Final Webinar to Boost Pediatric Innovation in Europe